CINCINNATI and EINDHOVEN, Netherlands, Feb. 27, 2025 /PRNewswire/ -- Mammotome, a globally recognized leader in breast care, and Sirius Medical, the innovator of Surgical Marker Navigation, are proud ...
Mammotome, a Danaher company, announces FDA Clearance of two innovations for MR-guided breast biopsy: the Mammotome Prima™ MR ...
Some four years ago, Tom Daulton was given $250 million by GTCR Golder Rauner LLC, a private equity firm that specializes in the health care industry, and was told to purchase a medical device company ...
HAMBURG, Germany, Feb. 18, 2026 /PRNewswire/ -- Mammotome, a Danaher company, announces the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System, the industry's first system designed to be ...
A Mammotome device, which is used to excise benign breast lumps from a patient, has been introduced at a private hospital in Madurai. Dr Suganya, Breast and Endocrine Surgeon said that benign lumps in ...
CINCINNATI, Aug. 21, 2023 /PRNewswire/ -- Mammotome announced the launch of an innovative new HydroMARK™ Plus Breast Biopsy Site Marker designed to enhance ultrasound visibility, improve ease of ...
At Mammotome, our expertise and compassion for breast care makes us an indispensable partner to physicians, clinicians and patients. Headquartered in Cincinnati, Ohio, with nine locations across the ...
The Mammotome AutoCoreTM system offers significant advantages over traditional core needle devices, saving valuable time for physicians and improving the patient experience.2 Developed with efficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results